US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalL
LFCR
Lifecore Biomedical Inc
5.06
0.45+9.76%Closed16:01 10/17 EDT
OPEN/PREV CLOSE4.770/4.610
TODAY RANGE4.590-5.07
VOL197.96K
MARKET CAP186.34M
52 WEEK RANGE3.679-8.90
AVG VOL (3M)229.83K
% TURNOVER0.54%
TURNOVER0
P/E (TTM)85.04
% RANGE10.44%
EPS(TTM)0.0595
P/E(FORWARD)-4.9126
P/B3.958
BVPS1.279
DIVIDEND--
P/S1.206
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP176.65M
SHARES OUTSTANDING36.83M
NEXT EARNINGS--
FREE FLOAT34.91M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Lifecore Biomedical GAAP EPS of -$0.53, revenue of $24.7M
Reuters·10/08 04:08
LIFECORE BIOMEDICAL INC <LFCR.O>: STEPHENS RAISES TARGET PRICE TO $6 FROM $5
TipRanks·10/07 13:15
Lifecore Biomedical: A Cautious Hold Amid Modest Growth and Financial Challenges
TipRanks·10/07 12:45
Craig-Hallum Remains a Buy on Lifecore Biomedical (LFCR)
TipRanks·10/05 09:01
Lifecore reports Q1 EPS (53c) vs. (35c) last year
TipRanks·10/05 09:01
Lifecore reiterates FY25 revenue view $126.5M – $130M, consensus $127.56M
TipRanks·10/05 08:48
Morning Movers: ZIM Integrated drops as dockworkers agree to end strike
TipRanks·10/05 08:33
Jobs data surprise to upside: Morning Buzz
Press release·10/04 12:23
Lifcore Biomedical, Inc. Reports Quarterly Results for the Fiscal Quarter Ended August 25, 2024
TipRanks·10/04 11:57
Lifecore Biomedical Raises $24.3M, Expands Capacity and Clientele
Dow Jones·10/04 11:31
*Lifecore Biomedical 1Q Rev $24.7M >LFCR
Dow Jones·10/04 11:31
*Lifecore Biomedical 1Q Loss $16.2M >LFCR
Reuters·10/04 11:30
LIFECORE BIOMEDICAL INC: REAFFIRMING GUIDANCE FOR FISCAL YEAR 2025
Same Industry
Name/Symbol
Change%
Price